Association between chronic atrophic gastritis and serum antibodies to 15 helicobacter pylori proteins measured by multiplex serology

Cancer Research

Volumn 69, Issue 7, 2009, Pages 2973-2980

  Gao, Lei ^a   Weck, Melanie N ^a   Michel, Angelika ^b   Pawlita, Michael ^b   Brenner, Hermann ^a  

^a German Cancer Research Center   (Norway)

^b Genome Modifications and Carcinogenesis   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; CHAPERONIN; HELICOBACTER CYSTEINE RICH PROTEIN C; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; VACUOLATING TOXIN; VIRULENCE FACTOR; BACTERIUM ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; ARTICLE; CANCER RISK; CHRONIC ATROPHIC GASTRITIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIGESTIVE SYSTEM INFLAMMATION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GERMANY; HELICOBACTER PYLORI; HUMAN; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEROLOGY; ATROPHIC GASTRITIS; BLOOD; CASE CONTROL STUDY; CHRONIC DISEASE; HELICOBACTER INFECTION; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED;

AGED; ANTIBODIES, BACTERIAL; CASE-CONTROL STUDIES; CHRONIC DISEASE; FEMALE; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED;

EID: 66149154702     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3477     Document Type: Article

References (50)

1. Correa P Haenszel W, Cuello C, Tannenbaum S, Archer M. A model, for gastric cancer epidemiology. Lancet 1975;2:58-60.
2. Forman D, Burley VJ. Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol. 2006;20:633-649.
3. Peek RM, Jr., Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002;2:28-37.
4. Kuipers EJ. Review article: exploring the link between Helicobacter pylori and gastric cancer. Aliment Pharma- oolTher 1999;3 Suppl.1:3-11.
5. Blaser MJ. Helicobacter pylori and the pathogenesis of gastroduodenal Inflammation. J Infect Dis I990;16I: 626-633.
6. Hamajima N1 Naito M1 Kondo T1 Goto Y. Genetic factors Involved in the development of Helicobacter pylori -related gastric cancer. Cancer Sei 2006:97:1129-1138.
7. Correa P1 Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology 2007;133:659-672.
8. Covacci A1 Telford JL1 Del Giudice G, Parsonnet J1 Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 1999;284:1328-1333.
9. Huang JQ1 Zheng GF1 Sumanac K, Irvine EJ1 Hunt RH. Meta-analysis of the relationship between CagA sero- positivity and gastric cancer. Gastroenterology 2003:125:.1636-1644.
10. Kuipers EJ1 Pérez-Pérez GI1 Meuwissen SG1 Blaser MJ. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J NaU Cancer Inst 1995;87:1777-1780.
11. Dhar SK1 Soni RK1 Das BK1 Mukhopadhyay G. Molecular mechanism of action, of major Helicobacter pylori virulence factors. MoI. Cell Biochem 2003;253: 207-215.
12. Lin YF1 Wu MS1 Chang CC1 et al. Comparative immunoproteomics of identification and characteriza- tion of virulence factors from Helicobacter pylori related to gastric cancer. MoI Cell. Proteomics 2006;5:1484-1496.
13. Mini R1 Bernardini G1 Salzano AM1 et al. Compar- ative proteomics and Immunoproteomics of Helico- bacter pylori related to different gastric pathologies. J Chromatogr B Analyt Technol Blomed Life Sci 2006: 833:63-79.
14. Haas G1 Karaali G1 Ebermayer K1 et al. Immunopro- teomics of Helicobacter pylori infection, and relation to gastric disease. Proteomics 2002;2:313-324.
15. Kimmel B Bosserhoff A Frank R Gross R Goebel W Beier D. Identification of immunodominant antigens from Helicobacter pylori and evaluation of their reactivities with sera from patients with different gastroduodenal, pathologies. Infect Immun 2000;68: 915-920.
16. Krah A Miehlke S Pleissner KP et al. Identification of candidate antigens for serologic detection of Helico- bacter pylori-irsiected patients with gastric carcinoma. Int J Cancer 2004;108:456-63.
17. Lu H Yamaoka Y Graham DY. Helicobacter pylori virulence factors: facts and fantasies. Curr OpIn Gastro- enterol 2005;21:653-659.
18. Atanassov C Pezennec L d'Alayer J, Grollier G Picard B Fauchera JL. Novel, antigens of Helicobacter pylori correspond to ulcer-related antibody pattern of sera from infected patients. J Clin Microbiol 2002;40:547-552.
19. Brenner H1 Rothenbacher D Week MN. Epidemio- logic findings on serologically defined chronic atrophic gastritis strongly depend on the choice of the cutoff- value. Int J Cancer 2007;121:2782-2786.
20. Week MN Brenner H. Prevalence of chronic atrophic gastritis in different parts of the world. Cancer Epidemiol Biomarkers Prev 2006;15:1083-1094.
21. Waterboer T Sehr P Michael. KM et al. Multiplex human papillomavirus serology based on in situ-purified glutathione S-transferase fusion proteins. Clin Chem. 2005;51:1845-1853.
22. Karnes WE Jr., Somloff IM, Siurala M, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991;101:167-174.
23. Kokkola A, Kosunen TU, Puolakkainen P, et al. Spontaneous disappearance of Helicobacter pylori anti- bodies in patients with advanced atrophic corpus gastritis. APMIS 2003;111:619-624.
24. Sipponen P, Hyvarinen H, Seppälä K, Blaser MJ. Review article: Pathogenesis of the transformation from gastritis to malignancy. Ailment Pharmacol Ther 1998; 12 Suppl 1:61-71.
25. Mobley HL. Defining Helicobacter pylori as a pathogen: strain heterogeneity and virulence. Am J Med 1996;100:2-9S.
26. Torres J, Pérez-Pérez GI, Leal-Herrera Y, Muñoz O. Infection with CagA+ Helicobacter pylori strains as a possible predictor of risk in the development of gastric adenocarcinoma in Mexico. Int J Cancer 1998: 78:298-300.
27. Palli D Másala G Del Giudice G et al. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study. Int J Cancer 2007;120: 859-867.
28. Eurohepygast Study Group. Risk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast study. Gut 2002;50:779-785.
29. Gwack J ShIn A Kim. CS et al. CagA-producIng Helicobacter pylori and increased risk of gastric cancer: a nested case-control study in Korea. Br J Cancer 2006; 95:639-641.
30. Rudi J KoIb C Maiwald M, et al. Serum antibodies against Helicobacter pylori proteins VacA and CagA. are associated with increased risk for gastric adenocarcino- ma. Dig Dis Sei 1997;42:1652-1659.
31. Ogura K1 Maeda S1 Nakao M1 et al. Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil. J Exp Med 2000;192:1601-1610.
32. Shimoyama T Neelam B Fukuda S Tanaka M Munakata A Crabtree JE. VacA seropositivity is not associated with the development of gastric cancer in a Japanese population. Eur J Gastroenterol Hepatol 1999; 11:887-890.
33. Harris AG Wilson JE Danon SJ Dixon MF Donegan K Hazell SL. Catalase (KatA) and KatA-associated protein (KapA) are essential to persistent colonization in the Helicobacter pylori SSl mouse model. Microbiol- ogy 2003;149:665-672.
34. Momynaliev KT Rogov SI Selezneva OV Chelysheva W Akoplan TA Govorun VM. Comparative analysis of transcription profiles of Helicobacter pylori clinical isolates. Biochemistry Mose 2005;70:383-390.
35. Satin. B Del. Giudlce G Delia Bianca V, et al. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J Exp Med 2000;191:1467-1476.
36. Kavermann H Burns BP Angermuller K et al. Identification and characterization of Helicobacter pylori genes essential for gastric colonization. J Exp Med 2003;197:813-822.
37. Sabarth N Hurwitz R Meyer TF Bumann D. Multiparameter selection of Helicobacter pylori antigens identifies two novel antigens with high protective efficacy. Infect Immun 2002;70:6499-6503.
38. Nystrům. J1 Svennerholm AM. Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that Is reflected by specific mucosal immune responses. Vaccine 2007;25:2591-2598.
39. Corthésy-Theulaz IE1 Hopkins S1 Bachmann D1 et al. Mice are protected from. Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhi- murium phoPc expressing urease A and B subunits. Infect Immun 1998;66:581-586.
40. Kleanthous H1 Myers GA1 Georgakopoulos KM1 et al. Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection. Infect Immun 1998;66:2879-2886.
41. Fischer W1 Puis J1 Buhrdorf R1 Gebert B1 Odenbreit S1 Haas R. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin- 8. MoI Microbiol 2001;42:1337-1348.
42. Kim N1 Weeks DL1 Shin JM1 Scott DR1 Young MK1 Sachs G. Proteins released by Helicobacter pylori in vitro. J Bacterio!. 2002;184:6155-6162.
43. Mittl PR1 Lüthy L1 Reinhardt C1 et al. Detection of high titers of antibody against Helicobacter cysteine- rich proteins A1 B1 C1 and E in. Helicobacter pylori- infected individuals. Clin Diagn Lab Immunol 2003:10: 542-545.
44. Demi L1 Aigner M1 Decker J1 et al. Characterization of the Helicobacter pylori cysteine-rich protein A as a T- helper cell type 1 polarizing agent Infect Immun 2005; 73:4732-4742.
45. Park JW1 Song JY1 Lee SG1 et al. Quantitative analysis of representative proteome components and clustering of Helicobacter pylori clinical strains. Helicobacter 2006; 11:533-543.
46. Bergonzelli GE1 Granato D1 Pridmore RD1 Marvin-Guy LF1 Donnicola D1 Corthésy-Theulaz IE. GroEL of Lactobacillus johmonii LaI (NCC 533) is cell, surface associated: potential role in interactions with the host and the gastric pathogen Helicobacter pylori. Infect Immun 2006:74:425-434.
47. Kansau I1 Labigne A. Heat shock, proteins of Helicobacter pylori. Aliment Pharmacol. Ther 1996;10: 51-56.
48. Andrew A1 Wyatt JI1 Dixon MF. Observer variation in. the assessment of chronic gastritis according to the Sydney system. Histopathology 1994;25:317-322.
49. Satoh K1 Kimura K1 Taniguchi Y1 et al. Biopsy sites suitable for the diagnosis of Helicobacter pylori infection and the assessment of the extent of atrophic gastritis. AmJ Gastroenterol 1998;93:569-573.
50. Storskrubb T1 Aro P1 Ronkainen J1 et al. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: the Kalixanda study. Scand J Gastroenterol 2008;43:1448-1455.